We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

38 hedge funds and large institutions have $6.85M invested in Biolase, Inc. in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 38 → 38 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

52% less capital invested

Capital invested by funds: $14.4M → $6.85M (-$7.56M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EIM
Essex Investment Management
Massachusetts
+$395K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$40.4K
3
APP
Avantax Planning Partners
Iowa
+$30.3K
4
HF
HRT Financial
New York
+$26.5K
5
ZF
Zhang Financial
Michigan
+$22.7K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$802K
2
Millennium Management
Millennium Management
New York
-$737K
3
Renaissance Technologies
Renaissance Technologies
New York
-$720K
4
Marshall Wace
Marshall Wace
United Kingdom
-$343K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.69M -$37.8K -30 -1%
PCM
2
Perkins Capital Management
Minnesota
$1.19M -$44.1K -35 -3%
BlackRock
3
BlackRock
New York
$1.18M +$6.31K +5 +0.4%
EIM
4
Essex Investment Management
Massachusetts
$617K +$395K +313 +98%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$516K – – –
State Street
6
State Street
Massachusetts
$163K – – –
Northern Trust
7
Northern Trust
Illinois
$110K – – –
Millennium Management
8
Millennium Management
New York
$45K -$737K -584 -93%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$31K +$40.4K +32 New
Marshall Wace
10
Marshall Wace
United Kingdom
$27K -$343K -272 -90%
Charles Schwab
11
Charles Schwab
California
$23K – – –
APP
12
Avantax Planning Partners
Iowa
$23K +$30.3K +24 New
ZF
13
Zhang Financial
Michigan
$22K +$22.7K +18 +360%
OCM
14
Orion Capital Management
California
$20K – – –
HF
15
HRT Financial
New York
$20K +$26.5K +21 New
Morgan Stanley
16
Morgan Stanley
New York
$19K -$5.04K -4 -17%
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$18K -$1.26K -1 -5%
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
$17K +$8.83K +7 +100%
Renaissance Technologies
19
Renaissance Technologies
New York
$15K -$720K -571 -97%
VCM
20
Virtue Capital Management
Tennessee
$14K +$17.7K +14 New
TSS
21
Two Sigma Securities
New York
$12K – – –
MA
22
MONECO Advisors
Connecticut
$11K – – –
Victory Capital Management
23
Victory Capital Management
Texas
$8K – – –
AWM
24
Apollon Wealth Management
South Carolina
$8K +$10.1K +8 New
BCM
25
Bayesian Capital Management
New York
$8K +$11.4K +9 New
1
2 3

BIOL Hedge Fund Activity: Q4 2021 in Review

38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2021, worth a combined $6.85M — down 52% from $14.4M a quarter earlier.

Fund positioning in BIOL was balanced in Q4 2021: 11 funds opened new positions, 11 closed out, 4 added to existing stakes and 11 trimmed.

The largest buyer was Essex Investment Management, adding an estimated $395K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $802K sold.

  • 38 institutional investors held Biolase, Inc. (BIOL) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $6.85M of Biolase, Inc. stock for Q4 2021, down 52% quarter-over-quarter.
  • 11 funds opened new Biolase, Inc. positions in Q4 2021 and 11 closed out, a net change of 0 holders.
  • The largest Biolase, Inc. buyer in Q4 2021 was Essex Investment Management, an estimated $395K added.
  • The largest Biolase, Inc. seller in Q4 2021 was GSA Capital Partners, an estimated $802K sold.

Based on aggregated 13F filings for Q4 2021.